Cheng CH - Search Results

1

An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients With Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistance-Associated Substitutions.

Huang CF, Hung CH, Cheng PN, Bair MJ, Huang YH, Kao JH, Hsu SJ, Lee PL, Chen JJ, Chien RN, Peng CY, Lin CY, Hsieh TY, Cheng CH, Dai CY, Huang JF, Chuang WL, Yu ML. Huang CF, et al. Among authors: cheng pn, cheng ch. J Infect Dis. 2019 Jul 19;220(4):557-566. doi: 10.1093/infdis/jiz154. J Infect Dis. 2019. PMID: 30957170 Clinical Trial.

2

The genotype distribution of hepatitis C in southeastern Taiwan: Clinical characteristics, racial difference, and therapeutic response.

Cheng CH, Chen HL, Lin IT, Wu CH, Lee YK, Wong MW, Bair MJ. Cheng CH, et al. Kaohsiung J Med Sci. 2015 Nov;31(11):597-602. doi: 10.1016/j.kjms.2015.09.006. Epub 2015 Nov 6. Kaohsiung J Med Sci. 2015. PMID: 26678941 Free article.

3

Application of chronic liver failure-sequential organ failure assessment score for the predication of mortality after esophageal variceal hemorrhage post endoscopic ligation.

Wong MW, Chen MJ, Chen HL, Kuo YC, Lin IT, Wu CH, Lee YK, Cheng CH, Bair MJ. Wong MW, et al. Among authors: cheng ch. PLoS One. 2017 Aug 2;12(8):e0182529. doi: 10.1371/journal.pone.0182529. eCollection 2017. PLoS One. 2017. PMID: 28767684 Free PMC article.

4

High frequencies of a favorable IL-28B rs8099917 polymorphism and the clinical implications in patients with HCV in one multiracial area of Taiwan.

Cheng CH, Lin CC, Chen HL, Lin IT, Wu CH, Lee YK, Wong MW, Bair MJ. Cheng CH, et al. Kaohsiung J Med Sci. 2017 Oct;33(10):510-515. doi: 10.1016/j.kjms.2017.06.005. Epub 2017 Jul 1. Kaohsiung J Med Sci. 2017. PMID: 28962822 Free article.

5

Genotype distribution and treatment response among incarcerated drug-dependent patients with chronic hepatitis C infection.

Cheng CH, Lin CC, Chen HL, Lin IT, Wu CH, Lee YK, Bair MJ. Cheng CH, et al. PLoS One. 2018 Feb 1;13(2):e0191799. doi: 10.1371/journal.pone.0191799. eCollection 2018. PLoS One. 2018. PMID: 29389957 Free PMC article.

6

Evaluation of cost-effectiveness of peginterferon plus ribavirin for chronic hepatitis C treatment and direct-acting antiviral agents among HIV-infected patients in the prison and community settings.

Chen CP, Cheng CY, Zou H, Cheng CH, Cheng SH, Chen CK, Chen CH, Bair MJ. Chen CP, et al. Among authors: cheng cy, cheng ch, cheng sh. J Microbiol Immunol Infect. 2019 Aug;52(4):556-562. doi: 10.1016/j.jmii.2018.10.002. Epub 2018 Oct 12. J Microbiol Immunol Infect. 2019. PMID: 30360951 Free article.

7

Long-term histological change in chronic hepatitis C patients who had received peginterferon plus ribavirin therapy with sustained virological response.

Chu CY, Cheng CH, Chen HL, Lin IT, Wu CH, Lee YK, Bair MJ. Chu CY, et al. Among authors: cheng ch. J Formos Med Assoc. 2019 Jul;118(7):1129-1137. doi: 10.1016/j.jfma.2018.11.005. Epub 2018 Nov 22. J Formos Med Assoc. 2019. PMID: 30472042 Free article.

8

Subgroup analysis of the predictive ability of aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 (FIB-4) for assessing hepatic fibrosis among patients with chronic hepatitis C.

Cheng CH, Chu CY, Chen HL, Lin IT, Wu CH, Lee YK, Hu PJ, Bair MJ. Cheng CH, et al. J Microbiol Immunol Infect. 2020 Aug;53(4):542-549. doi: 10.1016/j.jmii.2019.09.002. Epub 2019 Nov 29. J Microbiol Immunol Infect. 2020. PMID: 31831303 Free article.

9

Direct-acting antiviral therapy of chronic hepatitis C improves liver fibrosis, assessed by histological examination and laboratory markers.

Cheng CH, Chu CY, Chen HL, Lin IT, Wu CH, Lee YK, Hu PJ, Bair MJ. Cheng CH, et al. J Formos Med Assoc. 2021 May;120(5):1259-1268. doi: 10.1016/j.jfma.2020.11.018. Epub 2020 Dec 16. J Formos Med Assoc. 2021. PMID: 33339709 Free article.

10

Virus Elimination by Direct-Acting Antiviral Agents Impacts Glucose Homeostasis in Chronic Hepatitis C Patients.

Cheng CH, Chu CY, Chen HL, Lin IT, Wu CH, Lee YK, Bair MJ. Cheng CH, et al. Front Endocrinol (Lausanne). 2022 Jan 13;12:799382. doi: 10.3389/fendo.2021.799382. eCollection 2021. Front Endocrinol (Lausanne). 2022. PMID: 35095765 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,945 results

Search Page

Filters